Skip to content
    Blue Pool Capital logo

    Blue Pool Capital

    Hong KongFounded 2004

    Blue Pool Capital is a multi-strategy investment firm and family office based in Hong Kong, primarily managing the assets of Alibaba co-founder Joe Tsai and other principals. The firm raised $1 billion for its first private equity fund, Riverside, focusing on consumer, financial, and technology companies globally.

    Average disclosed round size is $250.7M (across 24 rounds with reported amounts).

    Find people at Blue Pool Capital on Goldilocks AI

    Portfolio

    23

    Fund Size

    $1B

    Top Stage

    Series B

    Last 12 Mo

    0

    Team

    JB

    Jason Banh

    Managing Director

    JL

    Jiayi Lou

    Principal

    FL

    Fang Li

    Vice President

    SC

    Sonja Cheung

    Vice President

    JY

    Jennifer Yung

    Analyst

    CW

    Christopher Wu

    Chief Investment Officer

    MZ

    Max Zuo

    Investment Professional

    WZ

    Wei Zhang

    Lead the global real assets investment strategy

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    28 investments
    CompanyRoundAmountDate
    Tabby logoTabbySeries E—Feb 2025
    Cambium Carbon logoCambium CarbonSeed—Dec 2023
    Tabby logoTabbySeries D$200MOct 2023
    GetYourGuide logoGetYourGuideSeries F$194MJun 2023
    Artifact Labs logoArtifact LabsSeed$3.3MMay 2023
    Tabby logoTabbySeries B$58MJan 2023
    FFanatics Holdings, Inc.Unknown$1.5BMar 2022
    FFanatics HoldingsUnknown$1.5BJan 2022
    LLifeMineSeries C$175MJan 2022
    Nex logoNexSeries B$25MSep 2021
    LifeMine Therapeutics logoLifeMine TherapeuticsSeries B$50MJan 2021
    NNEX TeamSeries B$25MJan 2021
    GetYourGuide logoGetYourGuideSeries F$75MJan 2020
    PPolygon ZeroSeed$450MJan 2019
    Brii Biosciences logoBrii BiosciencesGrowth—May 2018
    Fog Pharmaceuticals logoFog PharmaceuticalsSeries B$66MMay 2018
    Hua Medicine logoHua MedicineBridge$117.4MMar 2018
    GGRAIL, Inc.Series C$300MJan 2018
    LifeMine Therapeutics logoLifeMine TherapeuticsSeries A$55MSep 2017
    Lytro logoLytroBridge$60MJan 2017
    LifeMine Therapeutics logoLifeMine TherapeuticsSeries A$55MJan 2017
    Thrive logoThriveSeries A—Aug 2016
    PPolygon LabsUnknown$450M—
    FFast Break LabsSeed$6M—
    The Sandbox logoThe SandboxSeries B$93M—
    Page 1 of 2

    Top Co-Investors

    Last updated: 7 October 2026